New benzimidazole derivatives as antihistamine agents
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
一种化合物、烷基的技术,应用在新型苯并咪唑衍生物领域,能够解决缺乏活性等问题
Active Publication Date: 2017-08-29
FAES FARMA SA
View PDF8 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The present invention relates to a group of novel compounds with benzimidazole structure, which have effective selective H 1 Antihistamine activity, lack of activity on the central nervous system and cardiovascular system
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0102] Example 1. Synthesis of 2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethan-1-ol
[0103]
[0104] 2-Ethoxyethyl 4-methylbenzenesulfonate (2.4 g, 9.7 mmol) and KOH (0.71 g, 13 mmol) were added to 2-(4-(1H-benzo[d]imidazol-2-yl )piperidin-1-yl)ethan-1-ol (Intermediate A, 1.6 g, 5.1 mmol) in 10 ml of DMF. The reaction was heated to 40-45°C with stirring for 5-6 hours. Water (15ml) was added, and the mixture was washed with CH 2 Cl 2 (3 x 10ml) extraction. The organic layer was dried over anhydrous sodium sulfate, and the solvent was evaporated in vacuo to give an oil, which was subjected to flash chromatography (DCM / CH 3 OH 95:5) to afford 1 g (61.9% yield) of 2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazole-2- base) piperidin-1-yl) ethan-1-ol. 1 H-NMR (CDCl 3)7.7(m,1H),7.3-7.2(m,3H),4.3(t,2H),3.7(m,4H),3.4(c,2H),3.3-3.1(m,4H),2.7(m ,2H), 2.5(m,2H), 2.3-2.1(m,4H), 1.1(t,3H)ppm.
Embodiment 2
[0105] Example 2. 2-(1-(2-(2-ethoxyethoxy)ethyl)piperidin-4-yl)-1-(2-ethoxyethyl)-1H-benzo[ d] imidazole
[0106] In the same experiment as in Example 1 above, 0.3 g (15% yield) of the compound of Example 2 was also obtained in the form of a yellow oil. 1 H-NMR (CDCl 3 )7.7(m,1H),7.3-7.2(m,3H),4.3(t,2H),3.7(m,4H),3.4(c,2H),3.3-3.1(m,4H),2.7(m ,2H), 2.5(m,2H), 2.3-2.1(m,4H), 1.1(t,3H)ppm.
Embodiment 3
[0108] Example 3. 3-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)propan-1-ol. From the middle Body B and 2-ethoxyethyl 4-methylbenzenesulfonate
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, a method of synthesis of said compounds, pharmaceutical compositions comprising them and their use in the treatment and / or prevention of conditions mediated by H1 histamine receptor, such as allergic disorders or diseases.
Description
technical field [0001] The present invention relates to novel benzimidazole derivatives, methods of synthesis, pharmaceutical compositions containing them and their use as antihistamine and antiallergic agents. Background technique [0002] It has long been known that histamine plays a very important role in allergic diseases such as allergic rhinitis, conjunctivitis, rhinoconjunctivitis, dermatitis, urticaria and asthma. Histamine H 1 - Antihistamine compounds acting at the receptor level are used to treat such symptoms. [0003] The first generation H 1 Antihistamines produce many adverse effects due to their effects on the central nervous system and cholinergic receptors. [0004] The search for molecules that do not cross the blood-brain barrier has led to the replacement of earlier antihistamines by other second-generation antihistamines that overcome the side effects associated with their effects on the central nervous system. More recently, this new generation of ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.